Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance

Abstract

Metastasis, tumor progression, and chemoresistance are the major causes of death in patients with pancreatic ductal adenocarcinoma (PDAC). Tumor dissemination is associated with the activation of an epithelial-to-mesenchymal transition (EMT) process, a program by which epithelial cells lose their cell polarity and cell-to-cell adhesion, and acquire migratory and invasive abilities to become mesenchymal stem cells (MSC). These MSCs are multipotent stromal cells capable of differentiating into various cell types and trigger the phenotypic transition from an epithelial to a mesenchymal state. Therefore, EMT promotes migration and survival during cancer metastasis and confers stemness features to particular subsets of cells. Furthermore, a major problem limiting our ability to treat PDAC is the existence of rare populations of pancreatic cancer stem cells (PCSCs) or cancer-initiating cells in pancreatic tumors. PCSCs may represent sub-populations of tumor cells resistant to therapy which are most crucial for driving invasive tumor growth. These cells are capable of regenerating the cellular heterogeneity associated with the primary tumor when xenografted into mice. Therefore, the presence of PCSCs has prognostic relevance and influences the therapeutic response of tumors. PCSCs express markers of cancer stem cells (CSCs) including CD24, CD133, CD44, and epithelial specific antigen as well as the drug transporter ABCG2 grow as spheroids in a defined growth medium. A major difficulty in studying tumor cell dissemination and metastasis has been the identification of markers that distinguish metastatic cancer cells from cells that are normally circulating in the bloodstream or at sites where these cells metastasize. Evidence highlights a linkage between CSC and EMT. In this review, The current understanding of the PCSCs, signaling pathways regulating these cells, PDAC heterogeneity, EMT mechanism, and links between EMT and metastasis in PCSCs are summarised. This information may provide potential therapeutic strategies to prevent EMT and trigger CSC growth inhibition and cell death.

Keywords

Pancreatic cancer / cancer stem cells / epithelial-mesenchymal transition / metastasis / drug resistance

References

[1] Aier I,Sharma A.A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer..Cancer Epidemiol2019;58:104-10

[2] Sohal DP,Khorana AA,Philip PA.Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline..J Clin Oncol2016;34:2784-96 PMCID:PMC5019760

[3] Kleeff J,Apte M,Johnson CD.Pancreatic cancer..Nat Rev Dis Primers2016;2:16022

[4] Balic A,Alonso-Gómez M.Stem cells as the root of pancreatic ductal adenocarcinoma..Exp Cell Res2012;318:691-4

[5] Hassanein MK,Saji S,Bouvet M.Stem-like and non-stem human pancreatic cancer cells distinguished by morphology and metastatic behavior..J Cell Biochem2011;112:3549-54

[6] Berlin JD,Thomas JP,Haller DG.Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297..J Clin Oncol2002;20:3270-5

[7] Singh RR.New treatment strategies for metastatic pancreatic ductal adenocarcinoma..Drugs2020;80:647-69 PMCID:PMC7466866

[8] Lambert A,Conroy T.Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions..Therap Adv Gastroenterol2017;10:631-45 PMCID:PMC5557187

[9] Adamska A,Emmanouilidi A,Abdol Razak NB.Molecular and cellular mechanisms of chemoresistance in pancreatic cancer..Adv Biol Regul2018;68:77-87

[10] Hermann PC.Pancreatic cancer stem cells: a state or an entity?.Semin Cancer Biol2018;53:223-31

[11] Sergeant G,Gremeaux L.Role of cancer stem cells in pancreatic ductal adenocarcinoma..Nat Rev Clin Oncol2009;6:580-6

[12] Bednar F.Pancreatic cancer stem cells and relevance to cancer treatments..Cell Biochem2009;107:40-5

[13] Dembinski JL.Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma..Clin Exp Metastasis2009;26:611-23 PMCID:PMC2776152

[14] Vaz AP,Seshacharyulu P.A concise review on the current understanding of pancreatic cancer stem cells..J Cancer Stem Cell Res2014;2:e1004 PMCID:PMC4594952

[15] Mu W,Zöller M.Ping-pong-tumor and host in pancreatic cancer progression..Front Oncol2019;9:1359 PMCID:PMC6927459

[16] Tsai KK,Shaked Y.Next viable routes to targeting pancreatic cancer stemness: learning from clinical setbacks..J Clin Med2019;8:702 PMCID:PMC6571629

[17] Gzil A,Bursiewicz W,Grzanka D.Markers of pancreatic cancer stem cells and their clinical and therapeutic implications..Mol Biol Rep2019;46:6629-45

[18] Al-Hajj M,Benito-Hernandez A,Clarke MF.Prospective identification of tumorigenic breast cancer cells..Proc Natl Acad Sci U S A2003;100:3983-8 PMCID:PMC153034

[19] Shah AN,Zhang J,Parikh NU.Development and characterization of gemcitabine-resistant pancreatic tumor cells..Ann Surg Oncol2007;14:3629-37

[20] Hermann PC,Heeschen C.Metastatic cancer stem cells: a new target for anti-cancer therapy?.Cell Cycle2008;7:188-93

[21] Steinbichler TB,Skvortsov S,Riechelmann H.Therapy resistance mediated by cancer stem cells..Semin Cancer Biol2018;53:156-67

[22] Safa AR.Resistance to drugs and cell death in cancer stem cells (CSCs)..J Transl Sci2019;5:1-10

[23] Safa AR,Cohen-Gadol AA,Bijangi-Vishehsaraei K.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs..Genes Dis2015;2:152-63 PMCID:PMC4484766

[24] Chatterjee R.ROS and oncogenesis with special reference to EMT and stemness..Eur J Cell Biol2020;99:151073

[25] Garg M.Epithelial plasticity, autophagy and metastasis: potential modifiers of the crosstalk to overcome therapeutic resistance..Stem Cell Rev Rep2020;16:503-10

[26] Valle S,Alcalá S,Sainz B Jr.The ever-evolving concept of the cancer stem cell in pancreatic cancer..Cancers (Basel)2018;10:33 PMCID:PMC5836065

[27] Begum A,Jung C,Norberg KJ.The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma..PLoS One2017;12:e0180181 PMCID:PMC5503247

[28] Zhu H,Liu Y,Zhang L.Role of the hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells..Cancer Cell Int2013;13:119 PMCID:PMC4177138

[29] Santamaria-Martinez A.The niche under siege: Novel targets for metastasis therapy..J Intern Med2013;274:127136

[30] Singh SK,Clarke ID,Bayani J.Identification of human brain tumour initiating cells..Nature2004;432:396-401

[31] Ginestier C,Charafe-Jau EC,Dutcher J.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome..Cell Stem Cell2007;1:555-67 PMCID:PMC2423808

[32] Balic A,Alonso-Gómez M.Stem cells as the root of pancreatic ductal adenocarcinoma..Exp Cell Res2012;318:691-4

[33] Van den Hoogen C,Cheung H,Lippitt JM.High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer..Cancer Res2010;70:5163-73

[34] O’Brien CA,Gallinger S.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice..Nature2007;445:106-10

[35] Visvader JE.Cancer stem cells in solid tumours: accumulating evidence and unresolved questions..Nat Rev Cancer2008;8:755-68

[36] Malta TM,Gentles AJ,Poisson L.Machine learning identifies stemness features associated with oncogenic dedifferentiation..Cell2018;173:338-54.e15 PMCID:PMC5902191

[37] Patel AP,Trombetta JJ,Gillespie SM.Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma..Science2014;344:1396-401 PMCID:PMC4123637

[38] Wilson MM,Lees JA.Emerging mechanisms by which EMT programs control stemness..Trends Cancer2020;6:775-80

[39] Castellanos JA,Nagathihalli NS.Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells..Onco Targets Ther2013;6:1261-7 PMCID:PMC3775701

[40] Zhou P,Liu F,Wang Q.The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer..Mol Cancer2017;16:52 PMCID:PMC5331747

[41] Rodriguez-Aznar E,Sainz B Jr.EMT and stemness-Key players in pancreatic cancer stem cells..Cancers (Basel)2019;11:1136 PMCID:PMC6721598

[42] Brabletz T.To differentiate or not-Routes towards metastasis..Nat Rev Cancer2012;12:425-36

[43] Mani SA,Liao MJ,Ayyanan A.The epithelial-mesenchymal transition generates cells with properties of stem cells..Cell2008;133:704-15 PMCID:PMC2728032

[44] Pattabiraman DR.Tackling the cancer stem cells-What challenges do they pose?.Nat Rev Drug Discov2014;13:497-12 PMCID:PMC4234172

[45] Rhim AD,Aiello NM,Bailey JM.EMT and dissemination precede pancreatic tumor formation..Cell2012;148:349-61 PMCID:PMC3266542

[46] Scheel C,Li SH,Reinhardt F.Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast..Cell2011;145:926-40 PMCID:PMC3930331

[47] Ball CR,Ehrenberg KR,Dieter M.Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts..EMBO Mol Med2017;9:918-32 PMCID:PMC5494525

[48] Batlle E.Cancer stem cells revisited..Nat Med2017;23:1124-34

[49] Yang G,Wang W,Wu J.Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations..Br J Cancer2012;106:1512-9 PMCID:PMC3341854

[50] Dalla Pozza E,Biondani G,Costanzo C.Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi directionally convert into cancer stem cells..Int J Oncol2015;46:1099-108

[51] Erez N,Olson P,Hanahan D.Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner..Cancer Cell2010;17:135-47

[52] Bazzichetto C,Falcone I,Milella M.Advances in tumor-stroma interactions: Emerging role of cytokine network in colorectal and pancreatic cancer..J Oncol2019;2019:5373580 PMCID:PMC6525927

[53] Geismann C,Gundlach JP,Egberts JH.NF-κB dependent chemokine signaling in pancreatic cancer..Cancers (Basel)2019;11:1445 PMCID:PMC6826905

[54] Knapinska AM,Fields GB.The roles of matrix metalloproteinases in pancreatic cancer..Prog Mol Biol Transl Sci2017;148:339-54

[55] Mutgan AC,Wang S,Ceyhan GO.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer..Mol Cancer2018;17:66 PMCID:PMC5824531

[56] Lee NH,He H.Functions of the CXC ligand family in the pancreatic tumor microenvironment..Pancreatology2018;18:705-16

[57] Chen WJ,Chang YL,Lin CA.Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling..Nat Commun2014;5:3472

[58] Korkaya H,Wicha MS.Breast cancer stem cells, cytokine networks, and the tumor microenvironment..J Clin Investig2011;121:3804-9 PMCID:PMC3223613

[59] Tsuyada A,Wu J,Chu P.CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells..Cancer Res2012;72:2768-79 PMCID:PMC3367125

[60] Lonardo E,Mueller MT,Balic A.Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy..Cell Stem Cell2011;9:433-46

[61] Shi Y,Lytle NK,Yuan X.Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring..Nature2019;569:131-5 PMCID:PMC6565370

[62] Chan TS,Tsai KK.Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers..Front Oncol2019;9:688 PMCID:PMC6684765

[63] Hwang HJ,Lee DW.Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells..J Exp Clin Cancer Res2019;38:258 PMCID:PMC6567511

[64] Gieniec KA,Worthley DL.Cancer-associated fibroblasts-heroes or villains?.Br J Cancer2019;121:293-302 PMCID:PMC6738083

[65] Liu T,Li D,Zhang Y.Cancer-associated fibroblasts build and secure the tumor microenvironment..Front Cell Dev Biol2019;7:60 PMCID:PMC6492564

[66] Yin Z,Li R,Wang L.Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy..Mol Cancer2018;17:178 PMCID:PMC6309092

[67] Sainz B Jr,Garcia E,Azevedo MM.Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment..Gut2015;64:1921-35

[68] Iovanna JL.Factors released by the tumor far microenvironment are decisive for pancreatic adenocarcinoma development and progression..Oncoimmunology2017;6:e1358840 PMCID:PMC5674953

[69] Sainz B Jr,Tatari M,Guerra S.ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells..Cancer Res2014;74:7309-20

[70] Benson DD,Fullerton DA,Lee JH.Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma..Am J Physiol Regul Integr Comp Physiol2012;302:1067-75 PMCID:PMC4073963

[71] Waghray M,Dziubinski M,Erkkinen M.GM-CSF mediates mesenchymal-epithelial cross-talk in pancreatic cancer..Cancer Discov2016;6:886-99 PMCID:PMC5549011

[72] Osipov A,Zheng L.Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape..J Immunother Cancer2019;7:224 PMCID:PMC6704558

[73] Sanford DE,Panni RZ,Deshpande AD.Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2/CCR2 axis..Clin Cancer Res2013;19:3404-15 PMCID:PMC3700620

[74] Mitchem JB,Knolho BL,Zhu Y.Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses..Cancer Res2013;73:1128-41 PMCID:PMC3563931

[75] Jones EA,English A,Straszynski L.Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells..Arthritis Rheum2002;46:3349-60

[76] Kum JJ.Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis..Pediatr Res2014;75:381-8 PMCID:PMC3951485

[77] Kaplan RN,Lyden D.Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond..Cancer Metastasis Rev2006;25:521-9

[78] Shao H,Wang D,Boulina M.A novel stromal fibroblast-modulated 3D tumor spheroid model for studying tumor-stroma interaction and drug discovery..J Vis Exp2020;

[79] Wang CC,Wang HY.New insight into the role of exosomes in pancreatic cancer..Ann Clin Lab Sci2019;49:385-392

[80] Ercan G,Ozpolat B.Pancreatic cancer stem cells and therapeutic approaches..Anticancer Res2017;37:2761-75

[81] Venkatesh V,Thangaraj GS,Gnanasekaran A.Targeting Notch signalling pathway of cancer stem cells..Stem Cell Investig2018;5:5 PMCID:PMC5897708

[82] Xu YF,Ding WQ.MicroRNA regulation of human pancreatic cancer stem cells..Stem Cell Investig2017;4:5 PMCID:PMC5313281

[83] Bimonte S,Leongito M,Del Vecchio V.The role of miRNAs in the regulation of pancreatic cancer stem cells..Stem Cells Int2016;2016:8352684 PMCID:PMC4783541

[84] Lee HM,Choi KC.Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process..Mol Cell Endocrinol2017;457:103-13

[85] Chen X,Liu X,Luo L.Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells..Curr Mol Med2014;14:523-34

[86] Wang Y,Chai K,Zhou BP.The role of Snail in EMT and tumorigenesis..Curr Cancer Drug Targets2013;13:963-72 PMCID:PMC4004763

[87] Jiang X,Growney JD,Bottiglio C.Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma..Proc Natl Acad Sci USA2013;110:12649-54 PMCID:PMC3732970

[88] Katoh M.Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity..Int J Oncol2017;51:1357-69 PMCID:PMC5642388

[89] Onishi H.Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer..World J Gastroenterol2014;20:2335-42 PMCID:PMC3942836

[90] Ma Y,Shrivastava A,Lankachandra K.Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway..Carcinogenesis2017;38:1047-56

[91] Hebrok M.Hedgehog signaling in pancreas development..Mech Dev2003;120:45-57

[92] Yamasaki A,Imaizumi A,Fujimura A.Protein-bound polysaccharide-K inhibits Hedgehog signaling through down-regulation of MAML3 and RBPJ transcription under hypoxia, suppressing the malignant phenotype in pancreatic cancer..Anticancer Res2016;36:3945-52

[93] Chiorean EG.Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies..Drug Des Devel Ther2015;9:3529-45 PMCID:PMC4500614

[94] Lei J,Ma Q,Liu H.Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner..Mol Cancer2013;12:66 PMCID:PMC3699387

[95] Wang F,Zhang Z,Gao H.Hedgehog signaling regulates epithelial-mesenchymal transition in pancreatic cancer stem-like cells..J Cancer2016;7:408-17 PMCID:PMC4749361

[96] Crawford HC,Banerjee S.Signaling networks that control cellular plasticity in pancreatic tumorigenesis, progression, and metastasis..Gastroenterology2019;156:2073-84 PMCID:PMC6545585

[97] Cui J,Wang S,Xie K.Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer..Curr Pharm Des2012;18:2464-71

[98] Tanase CP,Necula LG,Enciu AM.Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics..World J Gastroenterol2014;20:10790-801 PMCID:PMC4138459

[99] Yao H,Maekawa T.Targeting the Wnt/β-catenin signaling pathway in human cancers..Expert Opin Ther Targets2011;15:873-87

[100] Bailey JM,Rasheed ZA,Fu YY.DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer..Gastroenterology2014;146:245-56 PMCID:PMC3910427

[101] Wang Z,Li Y,Miele L.Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy..Anticancer Res2011;31:1105-13

[102] Ma J,Miele L,Wang Z.Notch signaling pathway in pancreatic cancer progression..Pancreat Disord Ther2013;3:1000114 PMCID:PMC3767173

[103] Güngör C,Wolters-Eisfeld G.Pancreatic cancer..Br J Pharmacol2014;171:849-58 PMCID:PMC3925023

[104] Yabuuchi S,Campbell NR,De Oliveira E.Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer..Cancer Lett2013;335:41-51 PMCID:PMC3665739

[105] Wang Y,Jiao K,Liu Q.De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties..Exp Cell Res2020;386:111739

[106] Zakaria N,Zakaria Z,Yahaya BH.Inhibition of NF-κB signaling reduces the stemness characteristics of lung cancer stem cells..Front Oncol2018;8:166 PMCID:PMC5966538

[107] Zhang L,Li Y,Xie X.CCL21/CCR7 axis contributed to CD133+ pancreatic cancer stem-like cell metastasis via EMT and Erk/NF-κB pathway..PLoS One2016;11:e0158529 PMCID:PMC4978474

[108] Nomura A,Dauer P,Dudeja V.NFκB-mediated Invasiveness in CD133+ pancreatic TICs is regulated by autocrine and paracrine activation of IL1 signaling..Mol Cancer Res2018;16:162-72 PMCID:PMC5752573

[109] Zhang Z,Zhao H,Wu H.Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade..Cancer Lett2016;382:53-63

[110] Lai SW,Tsai WC,Lee WH.The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity..Clin Exp Metastasis2018;35:663-77

[111] Xu H,Qian X,Yan Y.GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells..Exp Ther Med2019;18:2608-16 PMCID:PMC6755448

[112] Zhou HY,Chen XD,Qiao ZG.Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gemcitabine by regulating the PI3K/Akt/mTOR signaling pathway..Eur Rev Med Pharmacol Sci2019;23:10283-9

[113] Meng Q,Hua J,Liu J.A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance..Theranostics2020;10:3967-79 PMCID:PMC7086345

[114] Yoshizawa N,Tameda M,Ikejiri M.miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreaticductal adenocarcinoma..Oncol Lett.2020;19:2677-84 PMCID:PMC7068395

[115] Shams R,Behmanesh A,Zali M.MicroRNAs targeting MYC expression: trace of hope for pancreatic cancer therapy. A systematic review..Cancer Manag Res2020;12:2393-404 PMCID:PMC7132265

[116] Han W,Liang J.Role of MicroRNA-30c in cancer progression..J Cancer2020;11:2593-601 PMCID:PMC7066027

[117] Jung DE,Oh T.Differentially expressed microRNAs in pancreatic cancer stem cells..Pancreas2011;40:1180-7

[118] Ji Q,Zhang M,Yang M.MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells..PLoS One.2009;4:e6816 PMCID:PMC2729376

[119] Wellner U,Burk UC,Zhu F.The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs..Nat Cell Biol2009;11:1487-95

[120] Smith BN.Role of EMT in metastasis and therapy resistance..J Clin Med2016;5:17 PMCID:PMC4773773

[121] Beuran M,Paun S,Bleotu C.The epithelial to mesenchymal transition in pancreatic cancer: a systematic review..Pancreatol2015;15:217-25

[122] Edderkaoui M,Soufi B,Hu RW.An inhibitor of GSK3B and HDACs kills pancreatic cancer cells and slows pancreatic tumor growth and metastasis in mice..Gastroenterology2018;155:1985-98 PMCID:PMC6328046

[123] Li K,Li A,Liu X.Exosomes play roles in sequential processes of tumor metastasis..Int J Cancer2019;144:1486-95

[124] Rodriguez-Aznar E,Sainz B Jr.EMT and stemness-Key players in pancreatic cancer stem cells..Cancers (Basel)2019;11:1136 PMCID:PMC6721598

[125] Banys-Paluchowski M,Fehm T.Disseminated tumor cells and dormancy in breast cancer progression..Adv Exp Med Biol2020;1220:35-43

[126] Dianat-Moghadam H,Eslami-S Z,Heidarifard M.The role of circulating tumor cells in the metastatic cascade: biology, technical challenges, and clinical relevance..Cancers (Basel)2020;12:867 PMCID:PMC7225923

[127] Aiello NM,Norgard RJ,Bhagwat N.Metastatic progression is associated with dynamic changes in the local microenvironment..Nat Commun2016;7:12819 PMCID:PMC5027614

[128] Lamouille S,Derynck R.Molecular mechanisms of epithelial-mesenchymal transition..Nat Rev Mol Cell Biol2014;15:178-96 PMCID:PMC4240281

[129] Rhim AD,Aiello NM,Bailey JM.EMT and dissemination precede pancreatic tumor formation..Cell2012;148:349-61 PMCID:PMC3266542

[130] Kalluri R.The basics of epithelial-mesenchymal transition..J Clin Invest2009;119:1420-8 PMCID:PMC2689101

[131] Forte E,Rosa P,Pagano F.EMT/MET at the crossroad of stemness, regeneration and oncogenesis: the ying-yang equilibrium recapitulated in cell spheroids..Cancers (Basel)2017;9:98 PMCID:PMC5575601

[132] Procacci P,Sartori P,Gagliano N.Tumor-stroma cross-talk in human pancreatic ductal adenocarcinoma: a focus on the effect of the extracellular matrix on tumor cell phenotype and invasive potential..Cells2018;7:158 PMCID:PMC6209911

[133] Begum A,Jung C,Norberg KJ.The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma..PLoS One2017;12:e0180181 PMCID:PMC5503247

[134] Pitarresi JR.Mechanisms underlying metastatic pancreatic cancer..Adv Exp Med Biol2019;1164:3-10

[135] Lawlor RT,Nottegar A,Smith L.Prognostic role of high-grade tumor budding in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis with a focus on epithelial to mesenchymal transition..Cancers (Basel)2019;11:113 PMCID:PMC6356259

[136] Pelosi E,Testa U.Pancreatic cancer: molecular characterization, clonal evolution and cancer stem cells.biomedicines.2017;5:65 PMCID:PMC5744089

[137] Kai F,Weaver VM.The extracellular matrix modulates the metastatic journey,.Dev Cell2019;49:332-6 PMCID:PMC6527347

[138] Najafi M,Mortezaee K.Cancer stem cells (CSCs) in cancer progression and therapy..J Cell Physiol2019;234:8381-95

[139] Celià-Terrassa T.Distinctive properties of metastasis-initiating cells.Genes Dev2016;30:892-908 PMCID:PMC4840296

[140] Agnoletto C,Minotti L,Crudele F.Heterogeneity in circulating tumor cells: the relevance of the stem-cell subset..Cancers (Basel)2019;11:483 PMCID:PMC6521045

[141] Giancotti FG.Mechanisms governing metastatic dormancy and reactivation..Cell2013;155:750-64 PMCID:PMC4354734

[142] Sosa MS,Aguirre-Ghiso JA.Mechanisms of disseminated cancer cell dormancy: an awakening field..Nat Rev Cancer2014;14:611-22 PMCID:PMC4230700

[143] Yang L,Zhao G,Feng W.Targeting cancer stem cell pathways for cancer therapy..Signal Transduct Target Ther.2020;5:8 PMCID:PMC7005297

[144] Crawford HC,Banerjee S.Signaling networks that control cellular plasticity in pancreatic tumorigenesis, progression, and metastasis gastroenterology..Gastroenterology2019;156:2073-84 PMCID:PMC6545585

[145] Hindriksen S.Cancer stem cells, EMT, and developmental pathway activation in pancreatic tumors.cancers (Basel)2012;4:989-35 PMCID:PMC3712732

[146] Chen C,Karnad A.The biology and role of CD44 in cancer progression: therapeutic implications.J Hematol Oncol2018;11:64 PMCID:PMC5946470

[147] Zhao S,Chang K,Jagirdar J.CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness and response to therapy..Clin Cancer Res2016;22:5592-604 PMCID:PMC5143222

[148] Nielsen MFB,Detlefsen S.Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations..World J Gastroenterol2018;24:4663-78 PMCID:PMC6224473

[149] Stokes JB1,Slack-Davis JK,Tilghman RW.Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment..Mol Cancer Ther2011;10:2135-45 PMCID:PMC3213273

[150] Miyazaki K,Hoshino D,Kumagai H.Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix..Sci Rep2019;9:292 PMCID:PMC6342997

[151] Sharma N,Sharma J,Singh KP.PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth..Oncotarget2015;6:32039-60 PMCID:PMC4741658

[152] Wang F,Yan XG,Yi ZG.Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells..Drug Des Devel Ther2015;9:575-601 PMCID:PMC4304576

[153] Makena DP,Verlekar D,Pandey MK.Wnt/β-Catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance..Int J Mol Sci2019;20:4242 PMCID:PMC6747343

[154] Razi E,Mahjoubin-Tehran M,Shafiee A.Cancer stem cells as therapeutic targets of pancreatic cancer..Fundam Clin Pharmacol.2020;34:202-12

[155] Okada M,Sato A,Suzuki S.Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation..Oncotarget2014;5:5100-12 PMCID:PMC4148125

[156] Wang Z,Banerjee S,Li Y.Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype..J Cell Physiol2016;231:2304 PMCID:PMC4943578

[157] Fitzgerald TL,Cocco L,Libra M.Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells..Adv Biol Regul2015;59:65-81

[158] Zhang B,Ren X,Zhou Q.Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer..Cancer Lett2019;10;459:204-15